Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia
Abstract Objective The aim of this study was to compare the effectiveness of two different protocols, labetalol with magnesium sulfate versus hydralazine with magnesium sulfate intravenous infusion with respect to their impact on maternal and fetal hemodynamics in severe preeclampsia. Patients and m...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-02-01
|
Series: | Ain Shams Journal of Anesthesiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s42077-019-0020-3 |
id |
doaj-4e9e1ae42a8a4483b788e9d33387cef9 |
---|---|
record_format |
Article |
spelling |
doaj-4e9e1ae42a8a4483b788e9d33387cef92020-11-25T02:26:13ZengSpringerOpenAin Shams Journal of Anesthesiology2090-925X2019-02-011111910.1186/s42077-019-0020-3Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsiaTamer Nabil Abdelrahman0Mohamed Abdelaziz Youssry1Ahmed M. Radwan2Anis Ahmed3Faculty of Medicine, Ain Shams UniversityFaculty of Medicine, Alexandria UniversityFaculty of Medicine, Zagazig UniversityDepartment of Radiology, IBN SINA College HospitalAbstract Objective The aim of this study was to compare the effectiveness of two different protocols, labetalol with magnesium sulfate versus hydralazine with magnesium sulfate intravenous infusion with respect to their impact on maternal and fetal hemodynamics in severe preeclampsia. Patients and methods In this prospective comparative randomized study, a total of 50 pregnant women in severe preeclampsia with gestational age ≥ 32 weeks were randomly recruited into two groups. Group A: 25 patients received labetalol with magnesium sulfate, and group B: 25 patients received hydralazine with magnesium sulfate by intravenous infusion in an escalating manner according to response until the target blood pressure ≤ 145/95 mmHg was achieved. Blood pressure, maternal heart rate, fetal heart rate, and Doppler ultrasound indices of umbilical and middle cerebral arteries were studied before and after treatment. Results A significant reduction of the maternal blood pressure was achieved in both groups, with significant reduction of maternal heart rate in group A. No significant changes in the umbilical and middle cerebral arteries pulsatility index, resistance index, and systolic/diastolic ratio before and after treatment were noted in both groups. Conclusion We concluded that both labetalol and hydralazine intravenous infusion regimens are well tolerated and effective in controlling severe hypertension in pregnant women with severe preeclampsia in combination with magnesium sulfate. Both drugs are reassuring as they are not related to any significant changes in fetoplacental circulation. Fetal heart rate did not change significantly after treatment in both groups.http://link.springer.com/article/10.1186/s42077-019-0020-3PreeclampsiaLabetalolHydralazineDoppler indices |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tamer Nabil Abdelrahman Mohamed Abdelaziz Youssry Ahmed M. Radwan Anis Ahmed |
spellingShingle |
Tamer Nabil Abdelrahman Mohamed Abdelaziz Youssry Ahmed M. Radwan Anis Ahmed Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia Ain Shams Journal of Anesthesiology Preeclampsia Labetalol Hydralazine Doppler indices |
author_facet |
Tamer Nabil Abdelrahman Mohamed Abdelaziz Youssry Ahmed M. Radwan Anis Ahmed |
author_sort |
Tamer Nabil Abdelrahman |
title |
Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia |
title_short |
Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia |
title_full |
Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia |
title_fullStr |
Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia |
title_full_unstemmed |
Impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia |
title_sort |
impact of intravenous infusion of labetalol combined with magnesium sulfate versus hydralazine combined with magnesium sulfate on fetomaternal hemodynamics in severe preeclampsia |
publisher |
SpringerOpen |
series |
Ain Shams Journal of Anesthesiology |
issn |
2090-925X |
publishDate |
2019-02-01 |
description |
Abstract Objective The aim of this study was to compare the effectiveness of two different protocols, labetalol with magnesium sulfate versus hydralazine with magnesium sulfate intravenous infusion with respect to their impact on maternal and fetal hemodynamics in severe preeclampsia. Patients and methods In this prospective comparative randomized study, a total of 50 pregnant women in severe preeclampsia with gestational age ≥ 32 weeks were randomly recruited into two groups. Group A: 25 patients received labetalol with magnesium sulfate, and group B: 25 patients received hydralazine with magnesium sulfate by intravenous infusion in an escalating manner according to response until the target blood pressure ≤ 145/95 mmHg was achieved. Blood pressure, maternal heart rate, fetal heart rate, and Doppler ultrasound indices of umbilical and middle cerebral arteries were studied before and after treatment. Results A significant reduction of the maternal blood pressure was achieved in both groups, with significant reduction of maternal heart rate in group A. No significant changes in the umbilical and middle cerebral arteries pulsatility index, resistance index, and systolic/diastolic ratio before and after treatment were noted in both groups. Conclusion We concluded that both labetalol and hydralazine intravenous infusion regimens are well tolerated and effective in controlling severe hypertension in pregnant women with severe preeclampsia in combination with magnesium sulfate. Both drugs are reassuring as they are not related to any significant changes in fetoplacental circulation. Fetal heart rate did not change significantly after treatment in both groups. |
topic |
Preeclampsia Labetalol Hydralazine Doppler indices |
url |
http://link.springer.com/article/10.1186/s42077-019-0020-3 |
work_keys_str_mv |
AT tamernabilabdelrahman impactofintravenousinfusionoflabetalolcombinedwithmagnesiumsulfateversushydralazinecombinedwithmagnesiumsulfateonfetomaternalhemodynamicsinseverepreeclampsia AT mohamedabdelazizyoussry impactofintravenousinfusionoflabetalolcombinedwithmagnesiumsulfateversushydralazinecombinedwithmagnesiumsulfateonfetomaternalhemodynamicsinseverepreeclampsia AT ahmedmradwan impactofintravenousinfusionoflabetalolcombinedwithmagnesiumsulfateversushydralazinecombinedwithmagnesiumsulfateonfetomaternalhemodynamicsinseverepreeclampsia AT anisahmed impactofintravenousinfusionoflabetalolcombinedwithmagnesiumsulfateversushydralazinecombinedwithmagnesiumsulfateonfetomaternalhemodynamicsinseverepreeclampsia |
_version_ |
1724848593952571392 |